Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Medimaging Integrated Solution EV-to-EBITDA?
Medimaging Integrated SolutionTPE:6796 +4.48%80 EV-to-EBITDA is 40.38 as of Aug. 22, 2026, which is 50% above its 10-year median of 26.88. GuruFocus rates TPE:6796 with a GF Score™ of 80/100 and a GF Value™ of NT$104.03 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 516 Medical Devices & Instruments companies, Medimaging Integrated Solution ranks worse than 84.5% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medimaging Integrated Solution's enterprise value is NT$2,634.1 Mil.
Medimaging Integrated Solution's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was NT$65.2 Mil. Therefore, Medimaging Integrated Solution's EV-to-EBITDA for today is 40.38.
The historical rank and industry rank for Medimaging Integrated Solution's EV-to-EBITDA or its related term are showing as below:
TPE:6796'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.43 Med: 26.88 Max: 68.12
Current: 40.38
During the past 8 years, the highest EV-to-EBITDA of Medimaging Integrated Solution was 68.12. The lowest was 11.43. And the median was 26.88.
TPE:6796's EV-to-EBITDA is ranked worse than 84.5% of 516
companies
in the Medical Devices & Instruments industry
Industry Median: 14.7
vs TPE:6796: 40.38
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medimaging Integrated Solution's PE Ratio (TTM) for today is calculated as:
Medimaging Integrated Solution's share price for today is NT$65.30.
Medimaging Integrated Solution's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-0.153.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6796 vs ABT, SYK, MDT: EV-to-EBITDA Comparison
For the Medical Devices subindustry, Medimaging Integrated Solution's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medimaging Integrated Solution EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medimaging Integrated Solution's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Medimaging Integrated Solution's EV-to-EBITDA falls into.
Medimaging Integrated Solution's current Enterprise Value is NT$2,634.1 Mil.
Medimaging Integrated Solution's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$65.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medimaging Integrated Solution (TPE:6796) has a EV-to-EBITDA of 40.38 as of Aug. 22, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Medimaging Integrated Solution. This is 50% above median its historical median of 26.88. Over the past decade, Medimaging Integrated Solution's EV-to-EBITDA has ranged from 11.43 to 68.12. According to the industry distribution chart, Medimaging Integrated Solution ranks #436 out of 516 companies in the Medical Devices & Instruments industry, placing it in the top 84.5%.
Is Medimaging Integrated Solution's EV-to-EBITDA too high?
Medimaging Integrated Solution's current EV-to-EBITDA of 40.38 is 50% above median its 10-year median of 26.88. Over the past 10 years, this metric has ranged from a low of 11.43 to a high of 68.12. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.70. Medimaging Integrated Solution's value of 40.38 is 174.7% above this industry median. Based on the distribution chart, Medimaging Integrated Solution ranks #436 out of 516 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medimaging Integrated Solution has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medimaging Integrated Solution's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medimaging Integrated Solution ranks #436 out of 516 companies for EV-to-EBITDA. This places Medimaging Integrated Solution in the lower half of its industry. The industry median EV-to-EBITDA is 14.70. Medimaging Integrated Solution's value of 40.38 is 174.7% above this benchmark. Historically, Medimaging Integrated Solution's own EV-to-EBITDA has ranged from 11.43 to 68.12 over the past decade. While the company's 10-year median is 26.88 vs. the industry median of 14.70, Medimaging Integrated Solution has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.70, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medimaging Integrated Solution's current EV-to-EBITDA of 40.38 is 174.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Medimaging Integrated Solution. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medimaging Integrated Solution's current EV-to-EBITDA is 40.38, which is 50% above median its own 10-year median of 26.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medimaging Integrated Solution stock overvalued right now?
Based on GuruFocus' analysis, Medimaging Integrated Solution (TPE:6796) is currently considered Possible Value Trap. The stock's GF Value™ is NT$104.03, compared to a current price of NT$65.30 — trading 37.2% below its estimated fair value. The current EV-to-EBITDA is 40.38, which is 50% above median its 10-year median of 26.88 and 174.7% above the Medical Devices & Instruments industry median of 14.70. Medimaging Integrated Solution's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Medimaging Integrated Solution (TPE:6796), the current EV-to-EBITDA is 40.38 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medimaging Integrated Solution (TPE:6796) Overvalued in 2026?
Based on GuruFocus' analysis, Medimaging Integrated Solution stock appears to be undervalued.
The current stock price of NT$65.30 is trading 37.2% below its estimated GF Value™ of NT$104.03.
GuruFocus considers Medimaging Integrated Solution to be Possible Value Trap.
Key valuation signals for TPE:6796:
EV-to-EBITDA: 40.38 (50% above median its 10-year median of 26.88)
GF Value™: NT$104.03 vs. price of NT$65.30 (37.2% below fair value)
Industry Position: 174.7% above the Medical Devices & Instruments median (#436 of 516)
No single metric tells the full story. See the TPE:6796 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medimaging Integrated Solution Inc and its subsidiaries are engaged in the design, manufacturing, and sales of digital medical imaging diagnostic equipment and related products and services. The company is a trusted partner of hospitals, medical schools, and health organizations, providing practitioners with digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes. Its products include Horus Scope, Smart Solutions, Endoscopy, and Micro Camera Modules.
80GF Score
Get the complete analysis for TPE:6796
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6796 has been successfully added to your 
